特集: 調査項目の変更・追加が可能なセミカスタムオーダー型の調査レポート(Lucintel社)はこちら

特集 : 国別の市場調査レポートをお探しの方はこちら

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

臨床栄養の世界市場:2020年~2024年

Global Clinical Nutrition Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 626540
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.13円で換算しております。
臨床栄養の世界市場:2020年~2024年 Global Clinical Nutrition Market 2020-2024
出版日: 2020年05月04日 ページ情報: 英文 120 Pages
概要

世界の臨床栄養市場は、2020年から2024年にかけて8%のCAGRで推移し、市場規模は2147万米ドルに達すると予測されています。高齢者人口の増加や、途上国の早産件数の増加などによって当市場の成長が促進されています。

当レポートでは、世界の臨床栄養市場を調査し、市場の概要、投与経路・地域別の市場規模の推移と予測、市場動向、市場の成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模
  • 市場の見通し

ファイブフォース分析

市場セグメンテーション:投与経路別

  • 市場区分:投与経路別
  • 市場比較:投与経路別
  • 経腸栄養
  • 経静脈栄養
  • 市場機会:投与経路別

顧客情勢

  • 概要

市場セグメンテーション:地域別

  • 市場区分:地域別
  • 市場比較:地域別
  • 北米
  • アジア太平洋地域
  • 欧州
  • その他の地域
  • 主要国
  • 市場機会:地域別
  • ボリューム成長 - 需要主導の成長
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline Plc
  • Lonza Group Ltd.
  • Nestle SA
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi

付録

目次
Product Code: IRTNTR43306

Technavio has been monitoring the clinical nutrition market and it is poised to grow by $ 21.47 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on clinical nutrition market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising geriatric population and increasing number of premature births in developing countries. In addition, rising geriatric population is anticipated to boost the growth of the market as well.

The clinical nutrition market analysis includes route of administration segment and geographic landscapes

Technavio's ‘ clinical nutrition market ’ is segmented as below:

By Route Of Administration

  • Enteral nutrition
  • Parenteral nutrition

By Geographic Landscape:

  • North America
  • APAC
  • Europe
  • ROW

This study identifies the increased number of medical emergencies and hospital admissions as one of the prime reasons driving the clinical nutrition market growth during the next few years.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our clinical nutrition market covers the following areas:

  • Clinical nutrition market sizing
  • Clinical nutrition market forecast
  • Clinical nutrition market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical nutrition market vendors that include Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Lonza Group Ltd., Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, and Sanofi. Also, the clinical nutrition market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Route of Administration

  • Market segments
  • Comparison by Route of Administration
  • Enteral nutrition - Market size and forecast 2019-2024
  • Parenteral nutrition - Market size and forecast 2019-2024
  • Market opportunity by Route of Administration

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • 8.1 Volume driver - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline Plc
  • Lonza Group Ltd.
  • Nestle SA
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1

2: Key Finding 2

3: Key Finding 3

4: Key Finding 5

5: Key Finding 6

6: Key Finding 7

7: Key Finding 8

8: Parent market

9: Market characteristics

10: Offerings of vendors included in the market definition

11: Market segments

12: Global - Market size and forecast 2019 - 2024 ($ million)

13: Global market: Year-over-year growth 2019 - 2024 (%)

14: Five forces analysis 2019 & 2024

15: Bargaining power of buyers

16: Bargaining power of suppliers

17: Threat of new entrants

18: Threat of substitutes

19: Threat of rivalry

20: Market condition - Five forces 2019

21: Other1 - Market share 2019-2024 (%)

22: Comparison by Other1

23: Enteral nutrition - Market size and forecast 2019-2024 ($ million)

24: Enteral nutrition - Year-over-year growth 2019-2024 (%)

25: Parenteral nutrition - Market size and forecast 2019-2024 ($ million)

26: Parenteral nutrition - Year-over-year growth 2019-2024 (%)

27: Market opportunity by Other1

28: Customer landscape

29: Market share by geography 2019-2024 (%)

30: Geographic comparison

31: North America - Market size and forecast 2019-2024 ($ million)

32: North America - Year-over-year growth 2019-2024 (%)

33: APAC - Market size and forecast 2019-2024 ($ million)

34: APAC - Year-over-year growth 2019-2024 (%)

35: Europe - Market size and forecast 2019-2024 ($ million)

36: Europe - Year-over-year growth 2019-2024 (%)

37: ROW - Market size and forecast 2019-2024 ($ million)

38: ROW - Year-over-year growth 2019-2024 (%)

39: Key leading countries

40: Market opportunity by geography ($ million)

41: Impact of drivers and challenges

42: Vendor landscape

43: Landscape disruption

44: Industry risks

45: Vendors covered

46: Market positioning of vendors

47: Abbott Laboratories - Overview

48: Abbott Laboratories - Business segments

49: Abbott Laboratories - Key offerings

50: Abbott Laboratories - Key customers

51: Abbott Laboratories - Segment focus

52: B. Braun Melsungen AG - Overview

53: B. Braun Melsungen AG - Business segments

54: B. Braun Melsungen AG - Key offerings

55: B. Braun Melsungen AG - Key customers

56: B. Braun Melsungen AG - Segment focus

57: Baxter International Inc. - Overview

58: Baxter International Inc. - Business segments

59: Baxter International Inc. - Key offerings

60: Baxter International Inc. - Key customers

61: Baxter International Inc. - Segment focus

62: Fresenius SE & Co. KGaA - Overview

63: Fresenius SE & Co. KGaA - Business segments

64: Fresenius SE & Co. KGaA - Key offerings

65: Fresenius SE & Co. KGaA - Key customers

66: Fresenius SE & Co. KGaA - Segment focus

67: GlaxoSmithKline Plc - Overview

68: GlaxoSmithKline Plc - Business segments

69: GlaxoSmithKline Plc - Key offerings

70: GlaxoSmithKline Plc - Key customers

71: GlaxoSmithKline Plc - Segment focus

72: Lonza Group Ltd. - Overview

73: Lonza Group Ltd. - Business segments

74: Lonza Group Ltd. - Key offerings

75: Lonza Group Ltd. - Key customers

76: Lonza Group Ltd. - Segment focus

77: Nestle SA - Overview

78: Nestle SA - Business segments

79: Nestle SA - Key offerings

80: Nestle SA - Key customers

81: Nestle SA - Segment focus

82: Pfizer Inc. - Overview

83: Pfizer Inc. - Business segments

84: Pfizer Inc. - Key offerings

85: Pfizer Inc. - Key customers

86: Pfizer Inc. - Segment focus

87: Reckitt Benckiser Group Plc - Overview

88: Reckitt Benckiser Group Plc - Business segments

89: Reckitt Benckiser Group Plc - Key offerings

90: Reckitt Benckiser Group Plc - Key customers

91: Reckitt Benckiser Group Plc - Segment focus

92: Sanofi - Overview

93: Sanofi - Business segments

94: Sanofi - Key offerings

95: Sanofi - Key customers

96: Sanofi - Segment focus

97: Currency conversion rates for US$

98: Research Methodology

99: Validation techniques employed for market sizing

100: Information sources

101: List of abbreviations